Navigation Links
Lumenis Ltd. Announces Appointment of Corporate Vice President, Business Development in support of the company's long-term growth strategy
Date:10/18/2007

Gideon Sturlesi has been named new Corporate Vice President, Business Development to spearhead global business activities. Lumenis reaffirms its commitment to growing its business and moving forward strongly on many

strategic fronts

YOKNEAM, Israel, Oct. 18 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications, announced the appointment of Gideon Sturlesi, a highly experienced executive in the medical devices industry, as Corporate Vice President, Business Development, effective November 18th 2007.

In addition to leading the corporate business development initiatives, Gideon will be responsible for managing the Lumenis veterinarian and dental activities, as well as the company's intellectual property strategy and portfolio.

Gideon Sturlesi was the founder and general partner of BioMedical Israel Ltd., a life-science private fund group, heading successful M&A processes, turn-arounds and "hands-on" management in it's portfolio companies. In addition, Gideon is a Venture Partner in the Ofer Hi-Tech Group, a leading investment company in life science technology-based businesses from pre-seed through early stages to public offerings. He was also the co-founder of Galil Medical Ltd., a developer of minimal invasive devices for use in urology, general surgery and other applications. Gideon Sturlesi holds a BSc and MSc (cum-laude) from the Technion Institute of Technology, Israel, and holds over 7 patents and publications in medical device technology.

Dov Ofer, CEO of Lumenis said: "We are proud to have Gideon Sturlesi as part of our executive management team. Gideon's background and proven capabilities will have a significant contribution in implementing our aggressive growth strategies. Gideon's appointment also supports the emphasis the company places on our intellectual property portfolio, one of Lumenis' major assets. With Gideon's appointment we have completed the line-up of our executive management team which is fully focused on executing our growth and profitability plans. I look forward to working hand in hand with our outstanding management team and Board of Directors to achieve Lumenis' fullest potential for the benefit of our customers, shareholders, employees and business partners."

About Lumenis Ltd.

Lumenis Ltd. is a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis Ltd. invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis Ltd. and its products, log onto: http://www.lumenis.com

Lumenis(R) is a registered trademark of Lumenis Ltd.


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):